| Authors: |
Daniel Syed Mohamed SM; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK.; PHAsT Limited, Sheffield, S1 4DP, UK., Tuffin J; The Discovery Centre (DISC), AstraZeneca PLC, Biomedical Campus, Cambridge, CB2 0AA, UK., Watson J; Renal Bristol, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY, UK., Mele A; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK.; PHAsT Limited, Sheffield, S1 4DP, UK., Fricker A; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK., Gregory DA; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK.; PHAsT Limited, Sheffield, S1 4DP, UK.; Insigneo Institute for in Silico Medicine, University of Sheffield, UK., Elghazy E; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK.; Department of Construction and Building Engineering, Arab Academy for Science, Technology, and Maritime Transport, Cairo, Egypt., Saleem MA; Renal Bristol, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY, UK., Satchell SC; Renal Bristol, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY, UK., Welsh GI; Renal Bristol, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY, UK., Roy I; School of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, S37HQ, UK.; PHAsT Limited, Sheffield, S1 4DP, UK.; Insigneo Institute for in Silico Medicine, University of Sheffield, UK. |